GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Seres Therapeutics MCRB · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.70

-14.14%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Seres Therapeutics

Our reporting

Next results

11 Mar 2027

Due on 11 Mar 2027. Analysts expect earnings of -1.37 a share on revenue of $6.4m.

Past results

Reported against what analysts expected

4 Nov 20265 Aug 20265 May 202612 Mar 20265 Nov 20256 Aug 2025
Earnings per share-1.630.47-2.08-1.780.94-2.27
Forecast-1.00-2.18-1.88-2.390.05-2.72
Revenue$593,000$736,000$358,000$438,000$351,000—
Forecast$6.3m$179,000$358,000$5.3m$7.8m$5.9m

Key events

  1. 22 Apr 202520-to-1 reverse split
  2. 26 Jun 2015Listed

Seres Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.